查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1470847

全球放射治療市場：按產品類型、治療、應用和最終用戶 - 預測 2024-2030

Radiotherapy Market by Product (Hardware, Software & Service), Type (External Beam Radiotherapy/Teletherapy, Internal Beam Radiotherapy/Brachytherapy, Systemic Radiotherapy), Procedure, Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球放射治療市場規模為66.4億美元，2024年達70.3億美元，預計2030年將達到100.1億美元，複合年成長率為6.04%。

放射治療領域是一個醫療和保健產業，利用放射線來治療方法癌症和一些非惡性疾病。它照射X光、伽瑪射線、帶電粒子束等高能量射線，主要破壞癌細胞、抑制增生、緩和症狀。世界上擴大採用放射療法來治療癌症，以及對微創治療的日益偏好正在影響放射治療世界的發展。相較之下，高昂的治療成本、訓練有素的專業人員有限以及與輻射暴露相關的風險限制了放射治療在全世界的使用。然而，一些供應商正在致力於研究和開發以克服這些問題。此外，全球放射治療設備的技術進步和改進以及癌症治療機器人放射治療全球系統的引入為開發和銷售尖端設備提供了商機。

主要市場統計
基準年[2023] 66.4億美元
預測年份 [2024] 70.3億美元
預測年份 [2030] 100.1億美元
複合年成長率（%） 6.04%

向產品腫瘤部位提供高劑量輻射的硬體製造過程的進步

硬體包含用於提供世界放射治療的所有有形元素。其中包括直線加速器、近距離放射治療、質子治療、電腦刀系統等。軟體服務部分是指用於規劃治療通訊協定、模擬輻射劑量以及管理患者資料和分析的平台。服務包括各種支援功能，包括設備維護、培訓、技術支援和諮詢。相較之下，硬體提供了提供治療的物理手段，而軟體和服務則確保精確定位、劑量規劃和無縫操作。

體外放射治療世界/遠距治療的目標是腫瘤外和大腫瘤，因此消費者更喜歡外照射。

外束放射治療 (EBRT)/遠距治療是一種常見的放射治療形式，其中放射線來自患者體外並傳遞到癌症部位。傳統的Cobalt-60遠端醫療裝置為癌症治療提供連續旋轉放射治療，是一種具有更深穿透能力的高效能裝置。 LINAC 向患者的腫瘤部位發送高能量 X光，破壞癌細胞的遺傳物質並抑制其生長。傳統的線性加速器使用微波技術來加速電子，然後與重金屬目標碰撞，產生高能量 X光。電腦刀斷層放射治療使用機械臂從多個角度照射腫瘤，達到精準治療。模組系統可調節輻射劑量，以盡量減少對健康組織的影響。伽瑪刀向受影響區域提供精確劑量的輻射，減少對健康腦組織的損害。 MRI 直線加速器使臨床醫生能夠即時觀察正在治療的腫瘤並根據需要調整治療。立體定位高級 Electron/Cobalt-60 直線加速器從多個角度提供高劑量輻射，在小區域內進行精確治療，最大限度地減少對周圍健康組織的影響。粒子治療系統使用帶電粒子精確瞄準癌細胞，可能最大限度地減少對周圍健康組織的輻射劑量，並降低副作用的風險。內部放射治療/近距離放射治療將高劑量的放射直接傳送到癌症部位及其附近，而不會傷害周圍的健康組織。它最常被選擇用於治療局部癌症，例如前列腺癌和子宮頸癌。後荷機旨在減少輻射醫療工作者的輻射暴露，加強病人安全政策並提高治療準確性。施用器是一種設計用於幫助將放射源定位在患者體內的治療部位的裝置。術中放射治療 (IORT) 系統是手術期間用於局部癌症治療的先進放射治療設備。種子是一種含有放射性物質的小型裝置。當小心地植入癌組織時，這些種子可以將輻射直接傳遞到腫瘤，從而最大限度地減少對周圍健康組織的損害。

碘苯胍 (i-131) 是一種被某些神經組織選擇性吸收的分子。這種獨特的特性使其成為診斷和治療神經內分泌腫瘤的寶貴工具。由於其伽馬射線特性，錸 186 同位素為醫療保健專業人員提供了一種利用醫學成像技術追蹤患者治療結果的典範方法，使先進醫學更進一步。 Samarium-153 具有雙重能力：BETA 粒子可瞄準並摧毀癌細胞，伽馬射線發射可促進生物分佈的成像和追蹤。

提升外束放射治療的世界，簡化手術流程並提升病患舒適度

體外照射療法（EBRT）是用於治療各種癌症的最常見的治療方法。 3D 適形放射治療可有效治療多種類型的癌症，並因其準確性和最大限度減少副作用的能力而受到高度評價。影像導引放射治療（IGRT）是一種先進的放射治療，在治療過程中涉及影像技術。強度調控放射治療(IMRT) 最佳化放射治療光束以配合腫瘤的形狀，使其能夠為癌症的不同部位提供不同強度的放射。粒子療法是一種獨特的治療方法，它使用帶電原子粒子向其穿過的組織傳遞低劑量，將能量集中在精確的點上。立體定位治療可以向小而明確的腫瘤提供高劑量，特別是在大腦和其他區域，同時最大限度地減少對鄰近正常組織的輻射，從而減少潛在的副作用。注射療法在放射治療領域，放射性物質被直接注射到體腔或膀胱中以治療表淺癌症。近距離放射治療涉及將放射源放置在腫瘤內部或旁邊，確保高劑量的輻射，同時不傷害健康組織。高劑量率 (HDR) 近距離放射治療旨在消滅癌細胞，同時最大限度地減少對周圍健康組織的暴露和損害。 LDR 近距離放射治療廣泛用於治療多種類型的癌症，包括子宮頸癌、攝護腺癌和眼部癌。脈衝劑量率 (PDR) 近距離放射治療涉及在限時放射週期內以脈衝方式提供輻射，通常每小時一次。該技術旨在最大限度地向腫瘤輸送劑量，同時保護周圍的健康組織。在靜脈注射放射治療領域，液體放射性物質會經由靜脈注射到體內。這種治療通常用於已擴散的癌症。在口腔放射治療領域，放射性物質以錠劑或液體形式攝取。用於治療甲狀腺癌等。全身性治療使用在全身循環的放射性藥物，適用於治療已擴散到骨骼或身體其他部位的癌症。

應用：擴大放射治療在全世界婦科癌症的應用

放射治療在乳癌治療中發揮重要作用，可顯著降低手術後乳房內復發的風險。在子宮頸癌的治療中，放射治療通常是單獨使用或與化療合併使用。世界對放射治療的需求高度依賴癌症的分期和定位。結直腸癌治療中的放射治療用於在手術前縮小腫瘤，並在手術後殺死剩餘細胞。放射線治療通常用於治療各種類型的婦科癌症。根據癌症的類型和階段，放射可用作主要治療、輔助性治療或安寧療護。放射治療在頭頸癌的治療中非常重要，並且經常與手術和化療結合使用。肺癌放射治療是一種主要的治療方法。儘管陰莖癌很少見，但放射線治療通常用作主要或輔助治療。放射治療對於局部前列腺癌的根治性非常有效。相較之下，由於併發症較少、局部控制和存活率較高，放射治療較常用於婦科癌症。

最終用戶：放射治療領域在為癌症患者提供全面護理的醫院服務中發揮著重要作用。

該醫院為癌症患者提供全面的護理，包括診斷和治療服務。將放射治療作為醫院內的綜合服務提供將有助於更好地協調護理，從而改善患者的預後。獨立的世界放射治療中心是一家為癌症患者提供放射治療的專業診所。這些中心為患者提供更個人化和便利的照護。儘管這些設施可能提供部分服務，但醫院通常能夠提供更有效率、以患者為中心的放射治療世界。醫院通常提供更廣泛的服務，可以為患有多種健康問題的患者提供全面的護理。另一方面，獨立的世界放射治療中心提供了一種更以患者為中心的方法，並且受到只尋求放射治療世界的患者的青睞。

區域洞察

放射治療在美洲的全球普及是由多種因素推動的，主要是癌症發生率的增加和對非侵入性治療方法的偏好。 3D 適形放射治療世界 (3D CRT) 和強度調控放射治療世界 (IMRT) 等先進技術正在推動該市場的成長。同時，政府針對癌症預防和控制的措施也是這一市場擴張的主要因素。在歐洲、中東和非洲地區，癌症發生率的上升增加了全世界對放射治療的需求。由於該地區觀察到的癌症病例種類繁多，放射治療成為首選的治療解決方案，可以提供有針對性的有效治療結果。全球創新放射治療設備的監管核准、普及的癌症研究和堅實的醫療保健框架進一步增強了市場。在亞太地區，由於癌症發生率上升，全球放射治療市場正在迅速擴大。一些國家的癌症發生率很高，這增加了對有效治療方法，包括放射治療領域。隨著早期診斷意識的提高、癌症治療機會的增加以及該領域的技術進步，該領域的成長得到了放大。亞太地區的新興國家也大力投資醫療基礎設施，進一步推動放療在全球的採用。

FPNV定位矩陣

FPNV定位矩陣對於評估全球放射治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對全球放射治療市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1. 全球放射治療市場的市場規模和預測是多少？

2.在全球放射治療市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.全球放射治療市場的技術趨勢和法規結構是什麼？

4.全球放射治療市場主要廠商的市場佔有率為何？

5.進入全球放射治療市場的合適模式和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球放射治療程序在癌症治療的採用增加
      • 人們對微創手術的興趣日益濃厚
      • 放射治療領域政府措施和計劃的增加
    • 抑制因素
      • 治療費用高且缺乏訓練有素的專業人員
    • 機會
      • 世界放射治療設備的技術進步與改進
      • 癌症治療機器人系統簡介
    • 任務
      • 與輻射暴露相關的風險
  • 市場區隔分析
    • 產品：向腫瘤部位提供高劑量輻射的硬體製造流程的進步
    • 類型：消費者偏好針對腫瘤外部和針對大腫瘤的外部放射治療/遠端醫療
    • 程序：外部光束的進步簡化了流程並提高了患者的舒適度
    • 應用：擴大婦科癌症放射治療的全球應用
    • 最終用戶：放射治療領域在為癌症患者提供全面護理的醫院服務中發揮著重要作用。
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章全球放射治療市場：依產品

  • 硬體
  • 軟體和服務

第7章全球放射治療市場：依類型

  • 外部放射治療/遠端醫療
  • 內束放射治療/近距離放射治療
  • 系統性放射治療的世界

第8章 全球放射治療市場：依治療分類

  • 體外放射治療的世界
  • 放射治療世界簡介
  • 內束放射治療或近距離放射的世界
  • 靜脈放射治療的世界
  • 口腔放射治療
  • 系統性放射治療的世界

第9章 全球放射治療市場：依應用分類

  • 乳癌
  • 子宮頸癌
  • 大腸直腸癌
  • 婦科癌症
  • 頭頸癌
  • 肺癌
  • 陰莖癌
  • 攝護腺癌

第10章全球放射治療市場：依最終使用者分類

  • 醫院
  • 獨立世界放射治療中心

第11章美洲放射治療的全球市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太放射治療全球市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的全球放射治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • CIVCO放療世界與Qfix推出CQ醫療品牌
    • GE 醫療集團與 Elekta 合作，擴大在印度獲得精準放射治療解決方案的機會
    • IBA推出最新放射治療品質保證服務
  • 戰略分析和建議

第15章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-42653751E6AE

[196 Pages Report] The Radiotherapy Market size was estimated at USD 6.64 billion in 2023 and expected to reach USD 7.03 billion in 2024, at a CAGR 6.04% to reach USD 10.01 billion by 2030.

Radiotherapy comprises businesses in the medical and healthcare sectors that harness radiation as a mode of treatment, typically for cancer and some non-malignant conditions. It involves deploying high-energy radiation, such as X-rays, gamma rays, and charged particles, primarily destroying cancerous cells, minimizing their growth, and reducing symptoms in palliative cases. The growing adoption of radiotherapy procedures for cancer treatment and rising preference for minimally invasive procedures influence the development of radiotherapy. In contrast, high treatment costs, limited availability of trained professionals, and risks associated with radiation exposure are restricting the utilization of radiotherapy. However, several vendors are working and investing in R&D to overcome these issues. Furthermore, technological advancements and improvements in radiotherapy devices and the introduction of robotic radiotherapy systems for cancer treatment are opportunities for businesses to create and market cutting-edge devices.

KEY MARKET STATISTICS
Base Year [2023] USD 6.64 billion
Estimated Year [2024] USD 7.03 billion
Forecast Year [2030] USD 10.01 billion
CAGR (%) 6.04%

Product: Advancements in hardware manufacturing process as it provide high radiation doses to the tumor site

The hardware encapsulates all the tangible elements employed in administering radiotherapy treatment. These include linear accelerators, brachytherapy devices, proton therapy, and cyber knife systems. The software and service segment refers to the platforms used to plan treatment protocols, simulate radiation doses, and manage patient data and analytics. Services encompass various support functions, including equipment maintenance, training, technical support, and consulting. In comparison, the hardware provides the physical means to deliver treatment, while software & service ensure precise targeting, dose planning, and seamless operation.

Type: Consumer preference for external beam radiotherapy/teletherapy as they target tumor from outside and large tumors

External beam radiotherapy (EBRT)/ teletherapy is a common form of radiation treatment where the radiation originates outside the patient and is directed toward the cancer site. Conventional cobalt-60 teletherapy units provide continuously rotating radiation therapy for cancer treatment and are highly efficient with deeper penetration capabilities. Linear accelerators (LINACs) deliver high-energy X-rays to the patient's tumor region, damaging the cancerous cells' genetic material and disrupting their growth. Conventional linear accelerators utilize microwave technology to accelerate electrons before colliding them with a heavy metal target, thus generating high-energy X-rays. Cyberknife tomotherapy allows precision treatment through a robotic arm that delivers multiple angles of radiation to a tumor. The system modulates the radiation dose, minimizing the impact on healthy tissue. Gamma knife has exact doses of radiation to the affected area, reducing damage to healthy brain tissues. MRI Linac allows clinicians to visualize the tumor in real-time during treatment and adapt therapy as needed. Stereotactic advanced electron/cobalt-60 linear accelerators deliver high doses of radiation from multiple angles to treat a small area with pinpoint accuracy, minimizing the impact on surrounding healthy tissues. Particle therapy systems use charged particles to target cancer cells precisely, minimizing the radiation dose to nearby healthy tissue and potentially reducing the risk of side effects. Internal beam radiotherapy/Brachytherapy involves radiation delivery directly into and near the cancer site, providing a high radiation dose while sparing surrounding healthy tissues. It's often the top choice for treating localized cancers such as prostate and cervical cancers. Afterloaders aim to reduce exposure to radiation health professionals, enhancing policies for patient safety and increasing treatment precision. Applicators are designed instruments intended to aid in positioning the radiation sources into the treatment site in a patient's body. Intraoperative radiation therapy (IORT) systems are advanced radiotherapeutic devices used during surgeries for localized cancer treatment. Seeds are tiny devices that encase radioactive materials. When carefully implanted into cancerous tissues, these seeds can deliver radiation directly to the tumor, minimizing damage to nearby healthy tissues.

Iobenguane (I-131) is a type of molecule that is selectively absorbed by certain types of nervous tissues. This unique characteristic makes it an invaluable tool in diagnosing and treating neuroendocrine tumors. Rhenium-186 isotope takes advanced medical science a step further by the exemplary way its gamma radiation properties enable medical professionals to track its effectiveness in patients with medical imaging technology. Samarium-153 has a dual capacity, its beta particles target and destroy cancer cells, its gamma emissions facilitate imaging and tracking its distribution through the body.

Procedure: Increasing advancements in external beam radiotherapy to streamline process and improve patient comfort

External Beam Radiotherapy (EBRT) is the most typical radiotherapy used to treat various cancers. 3D conformal radiotherapy effectively treats many types of cancers and is well-regarded for its precision and ability to minimize side effects. Image-guided Radiotherapy (IGRT) is an advanced form of radiotherapy involving imaging techniques during treatment delivery. Intensity-modulated Radiotherapy (IMRT) allows the radiotherapy beam to be optimized to the tumor's shape, allowing differing degrees of radiation intensity to various parts of the cancer. Particle therapy uniquely uses charged atomic particles, providing a low dose to the tissues they pass through and then depositing their energy at a precise point. Stereotactic therapy allows for high-dose delivery, particularly to small, well-defined tumors in the brain and other sites, while minimizing the radiation to adjacent normal tissues, thus mitigating potential side effects. Instillation radiotherapy involves injecting a radioactive substance directly into a body cavity or the bladder to treat superficial cancers. Brachytherapy is radiotherapy where the radioactive source is placed inside or next to the tumor, ensuring high-dose radiation while sparing healthy tissues. High-dose-rate (HDR) brachytherapy aims to destroy cancer cells while minimizing the exposure and damage to surrounding healthy tissues. LDR brachytherapy has been extensively used for treating numerous types of cancers, including cervical, prostate, and eye cancer. Pulsed-dose-rate (PDR) brachytherapy involves temporally confined radiation delivery cycles where radiation is emitted in pulses, usually once per hour. This technique seeks to maximize the tumor's dose delivery while safeguarding the surrounding healthy tissue. Intravenous Radiotherapy involves administering liquid radioactive substances into the body via a vein. This treatment is typically used for cancers that have spread or metastasized. Oral Radiotherapy involves ingesting radioactive substances through a pill or liquid. Notable for treating conditions such as thyroid cancer. Systemic radiotherapy uses radiopharmaceuticals that circulate throughout the body, ideal for treating cancers that have spread to bones or multiple sites.

Application: Growing application of radiotherapy for gynecological cancer

Radiotherapy plays a substantial role in breast cancer treatment, substantially reducing the reoccurrence risk within the breast area after surgery. Cervical cancer treatment frequently incorporates radiotherapy either alone or combined with chemotherapy. The need for radiotherapy heavily relies on the cancer stage and localization. Radiotherapy for colorectal cancer treatment is used before surgery to shrink the tumor and after the surgery to kill the remaining cells. Radiation therapy is commonly used to treat various types of gynecological cancers. Depending upon the type and stage of the cancer, radiation is used as primary therapy, adjunctive therapy, or palliative therapy. Radiotherapy is crucial in managing head and neck cancers, often in conjunction with surgery and chemotherapy. Radiotherapy for lung cancer serves as a primary mode of treatment. Penile cancer, although rare, often uses radiation therapy as a primary or supplementary treatment. Radiotherapy is very effective in curative treatment of localized prostate cancer. In comparison, radiotherapy is mostly used for gynecological cancer as it results in local control and survival with few complications.

End-User: Significant role of radiotherapy for hospitals service as they provide comprehensive care for cancer patients

Hospitals provide comprehensive care for cancer patients, including diagnostic and therapeutic services. The offering of radiotherapy as an integrated service within the hospital setting allows for better coordination of care, leading to improved patient outcomes. Independent radiotherapy centers are specialized clinics that offer radiation therapy to cancer patients. These centers provide patients with more personalized and convenient care. While these entities may offer a partial range of services, hospitals can often provide radiotherapy treatment more efficiently and patient-centeredly. Hospitals typically have a broader range of services, enabling them to provide holistic care, drawing patients dealing with multiple health issues. On the other hand, independent radiotherapy centers offer a more patient-centric approach, preferred by patients only seeking radiotherapy.

Regional Insights

The adoption of radiotherapy in the Americas is driven by various factors, primarily increasing cancer prevalence rates and a general preference for non-invasive treatment methods. Advanced technologies such as 3D conformal radiotherapy (3D CRT) and intensity-modulated radiotherapy (IMRT) contribute to this market's growth. Simultaneously, government initiatives focusing on cancer prevention and control are a significant factor behind this market's expansion. EMEA region has an increasing need for radiotherapy due to rising cancer incidents. With diverse cancer cases observed across the region, radiotherapy becomes a preferred treatment solution, offering targeted and efficient treatment outcomes. Regulatory approvals for innovative radiotherapy devices, the proliferation of cancer research, and robust healthcare frameworks further bolster the market. The APAC region is witnessing a rapid expansion in the radiotherapy market driven by the escalating burden of cancer. Several countries have high cancer rates, fueling the need for effective treatment modalities, including radiotherapy. The sector's growth is amplified by increasing awareness about early diagnosis, improved access to cancer treatments, and technological advancements within this domain. APAC's emerging economies are also investing heavily in healthcare infrastructure, which further propels the adoption of radiotherapy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Radiotherapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Radiotherapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Radiotherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Agilent Technologies Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Charles River Laboratories International, Inc., Elekta AB, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., IBA Dosimetry GmbH, IntraOp Medical, Inc., Koninklijke Philips N.V., Leo Cancer Care, Mevion Medical Systems, Panacea Medical Technologies Pvt. Ltd., PerkinElmer, Inc., Qfix, Quanterix Corporation, Radiology Oncology Systems, Siemens AG, Varian Medical Systems, Inc., ViewRay Technologies, Inc., and ZEISS Group.

Market Segmentation & Coverage

This research report categorizes the Radiotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Hardware
    • Software & Service
  • Type
    • External Beam Radiotherapy/Teletherapy
      • Conventional Cabalt-60 Teletherapy Units
      • Linear Accelerators
        • Conventional Linear Accelerators
        • CyberKnife TomoTherapy
        • Gamma Knife
        • MRI LINAC
        • Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
      • Particle Therapy Systems
        • Cyclotrons
        • Synchrocyclotron
        • Synchrotrons
    • Internal Beam Radiotherapy/Brachytherapy
      • Afterloaders
      • Applicators
      • IORT Systems
      • Seeds
    • Systemic Radiotherapy
      • lobenguane (l-131)
      • Rhenium-186
      • Samarium-153
  • Procedure
    • External Beam Radiotherapy
      • 3D Conformal Radiotherapy
      • Image-Guided Radiotherapy
      • Intensity-Modulated Radiotherapy
      • Particle Therapy
      • Stereotactic Therapy
    • Instillation Radiotherapy
    • Internal Beam Radiotherapy or Brachytherapy
      • High-Dose-Rate Brachytherapy
      • Low-Dose-Rate Brachytherapy
      • Pulsed-Dose-Rate Brachytherapy
    • Intravenous Radiotherapy
    • Oral Radiotherapy
    • Systemic Radiotherapy
  • Application
    • Breast Cancer
    • Cervical Cancer
    • Colorectal Cancer
    • Gynecological Cancer
    • Head & Neck Cancer
    • Lung Cancer
    • Penile Cancer
    • Prostate Cancer
  • End-User
    • Hospitals
    • Independent Radiotherapy Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Radiotherapy Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Radiotherapy Market?

3. What are the technology trends and regulatory frameworks in the Radiotherapy Market?

4. What is the market share of the leading vendors in the Radiotherapy Market?

5. Which modes and strategic moves are suitable for entering the Radiotherapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing adoption of radiotherapy procedures for cancer treatment
      • 5.1.1.2. Rising preference for minimally invasive procedures
      • 5.1.1.3. Increasing government initiatives and programs for radiotherapy
    • 5.1.2. Restraints
      • 5.1.2.1. High treatment costs and limited availability of trained professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and improvements in radiotherapy devices
      • 5.1.3.2. Introduction of robotic radiotherapy systems for cancer treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with radiation exposure
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Advancements in hardware manufacturing process as it provide high radiation doses to the tumor site
    • 5.2.2. Type: Consumer preference for external beam radiotherapy/teletherapy as they target tumor from outside and large tumors
    • 5.2.3. Procedure: Increasing advancements in external beam radiotherapy to streamline process and improve patient comfort
    • 5.2.4. Application: Growing application of radiotherapy for gynecological cancer
    • 5.2.5. End-User: Significant role of radiotherapy for hospitals service as they provide comprehensive care for cancer patients
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Radiotherapy Market, by Product

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Software & Service

7. Radiotherapy Market, by Type

  • 7.1. Introduction
  • 7.2. External Beam Radiotherapy/Teletherapy
  • 7.3. Internal Beam Radiotherapy/Brachytherapy
  • 7.4. Systemic Radiotherapy

8. Radiotherapy Market, by Procedure

  • 8.1. Introduction
  • 8.2. External Beam Radiotherapy
  • 8.3. Instillation Radiotherapy
  • 8.4. Internal Beam Radiotherapy or Brachytherapy
  • 8.5. Intravenous Radiotherapy
  • 8.6. Oral Radiotherapy
  • 8.7. Systemic Radiotherapy

9. Radiotherapy Market, by Application

  • 9.1. Introduction
  • 9.2. Breast Cancer
  • 9.3. Cervical Cancer
  • 9.4. Colorectal Cancer
  • 9.5. Gynecological Cancer
  • 9.6. Head & Neck Cancer
  • 9.7. Lung Cancer
  • 9.8. Penile Cancer
  • 9.9. Prostate Cancer

10. Radiotherapy Market, by End-User

  • 10.1. Introduction
  • 10.2. Hospitals
  • 10.3. Independent Radiotherapy Centers

11. Americas Radiotherapy Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Radiotherapy Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Radiotherapy Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. CIVCO Radiotherapy and Qfix Launch CQ Medical Brand
    • 14.3.2. GE HealthCare Collaborates with Elekta to Expand Access to Precision Radiation Therapy Solutions in India
    • 14.3.3. IBA Launches Latest Radiation Therapy Quality Assurance Offerings
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. RADIOTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. RADIOTHERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. RADIOTHERAPY MARKET DYNAMICS
  • FIGURE 7. GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL RADIOTHERAPY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL RADIOTHERAPY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RADIOTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RADIOTHERAPY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL RADIOTHERAPY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL RADIOTHERAPY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL RADIOTHERAPY MARKET SIZE, BY HARDWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL RADIOTHERAPY MARKET SIZE, BY SOFTWARE & SERVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL RADIOTHERAPY MARKET SIZE, BY SOFTWARE & SERVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL CABALT-60 TELETHERAPY UNITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL CABALT-60 TELETHERAPY UNITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL LINEAR ACCELERATORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL LINEAR ACCELERATORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL RADIOTHERAPY MARKET SIZE, BY CYBERKNIFE TOMOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL RADIOTHERAPY MARKET SIZE, BY CYBERKNIFE TOMOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL RADIOTHERAPY MARKET SIZE, BY GAMMA KNIFE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL RADIOTHERAPY MARKET SIZE, BY GAMMA KNIFE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL RADIOTHERAPY MARKET SIZE, BY MRI LINAC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL RADIOTHERAPY MARKET SIZE, BY MRI LINAC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL RADIOTHERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL RADIOTHERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYNCHROCYCLOTRON, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYNCHROCYCLOTRON, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL RADIOTHERAPY MARKET SIZE, BY AFTERLOADERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL RADIOTHERAPY MARKET SIZE, BY AFTERLOADERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL RADIOTHERAPY MARKET SIZE, BY IORT SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL RADIOTHERAPY MARKET SIZE, BY IORT SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL RADIOTHERAPY MARKET SIZE, BY SEEDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL RADIOTHERAPY MARKET SIZE, BY SEEDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL RADIOTHERAPY MARKET SIZE, BY LOBENGUANE (L-131), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL RADIOTHERAPY MARKET SIZE, BY LOBENGUANE (L-131), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL RADIOTHERAPY MARKET SIZE, BY RHENIUM-186, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL RADIOTHERAPY MARKET SIZE, BY RHENIUM-186, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL RADIOTHERAPY MARKET SIZE, BY SAMARIUM-153, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL RADIOTHERAPY MARKET SIZE, BY SAMARIUM-153, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL RADIOTHERAPY MARKET SIZE, BY 3D CONFORMAL RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL RADIOTHERAPY MARKET SIZE, BY 3D CONFORMAL RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL RADIOTHERAPY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL RADIOTHERAPY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTENSITY-MODULATED RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTENSITY-MODULATED RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL RADIOTHERAPY MARKET SIZE, BY INSTILLATION RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL RADIOTHERAPY MARKET SIZE, BY INSTILLATION RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 85. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 86. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 87. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 88. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 89. GLOBAL RADIOTHERAPY MARKET SIZE, BY HIGH-DOSE-RATE BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 90. GLOBAL RADIOTHERAPY MARKET SIZE, BY HIGH-DOSE-RATE BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 91. GLOBAL RADIOTHERAPY MARKET SIZE, BY LOW-DOSE-RATE BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 92. GLOBAL RADIOTHERAPY MARKET SIZE, BY LOW-DOSE-RATE BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 93. GLOBAL RADIOTHERAPY MARKET SIZE, BY PULSED-DOSE-RATE BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 94. GLOBAL RADIOTHERAPY MARKET SIZE, BY PULSED-DOSE-RATE BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 95. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTRAVENOUS RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 96. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTRAVENOUS RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 97. GLOBAL RADIOTHERAPY MARKET SIZE, BY ORAL RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 98. GLOBAL RADIOTHERAPY MARKET SIZE, BY ORAL RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 99. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 100. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 101. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. GLOBAL RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 104. GLOBAL RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 105. GLOBAL RADIOTHERAPY MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 106. GLOBAL RADIOTHERAPY MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 107. GLOBAL RADIOTHERAPY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 108. GLOBAL RADIOTHERAPY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 109. GLOBAL RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 110. GLOBAL RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 111. GLOBAL RADIOTHERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 112. GLOBAL RADIOTHERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 113. GLOBAL RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 114. GLOBAL RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 115. GLOBAL RADIOTHERAPY MARKET SIZE, BY PENILE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 116. GLOBAL RADIOTHERAPY MARKET SIZE, BY PENILE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 117. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 118. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 119. GLOBAL RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 120. GLOBAL RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 121. GLOBAL RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 122. GLOBAL RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 123. GLOBAL RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 124. GLOBAL RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 125. AMERICAS RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 126. AMERICAS RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 127. AMERICAS RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. AMERICAS RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. AMERICAS RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
  • TABLE 130. AMERICAS RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
  • TABLE 131. AMERICAS RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
  • TABLE 132. AMERICAS RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
  • TABLE 133. AMERICAS RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 134. AMERICAS RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 135. AMERICAS RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 136. AMERICAS RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 137. AMERICAS RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 138. AMERICAS RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 139. AMERICAS RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 140. AMERICAS RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 141. AMERICAS RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 142. AMERICAS RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 143. AMERICAS RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 144. AMERICAS RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 145. AMERICAS RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. AMERICAS RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. AMERICAS RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. AMERICAS RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. AMERICAS RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 150. AMERICAS RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 151. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 152. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 153. ARGENTINA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. ARGENTINA RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. ARGENTINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
  • TABLE 156. ARGENTINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
  • TABLE 157. ARGENTINA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
  • TABLE 158. ARGENTINA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
  • TABLE 159. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 160. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 161. ARGENTINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 162. ARGENTINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 163. ARGENTINA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 164. ARGENTINA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 165. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 166. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 167. ARGENTINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 168. ARGENTINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 169. ARGENTINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 170. ARGENTINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 171. ARGENTINA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. ARGENTINA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. ARGENTINA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. ARGENTINA RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. BRAZIL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. BRAZIL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. BRAZIL RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. BRAZIL RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. BRAZIL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
  • TABLE 180. BRAZIL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
  • TABLE 181. BRAZIL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
  • TABLE 182. BRAZIL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
  • TABLE 183. BRAZIL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 184. BRAZIL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 185. BRAZIL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 186. BRAZIL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 187. BRAZIL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 188. BRAZIL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 189. BRAZIL RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 190. BRAZIL RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 191. BRAZIL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 192. BRAZIL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 193. BRAZIL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 194. BRAZIL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 195. BRAZIL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. BRAZIL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. BRAZIL RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. BRAZIL RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. CANADA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 200. CANADA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 201. CANADA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. CANADA RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. CANADA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
  • TABLE 204. CANADA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
  • TABLE 205. CANADA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
  • TABLE 206. CANADA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
  • TABLE 207. CANADA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 208. CANADA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 209. CANADA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 210. CANADA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 211. CANADA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 212. CANADA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 213. CANADA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 214. CANADA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 215. CANADA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 216. CANADA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 217. CANADA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 218. CANADA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 219. CANADA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. CANADA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. CANADA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. CANADA RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. MEXICO RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. MEXICO RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. MEXICO RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. MEXICO RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. MEXICO RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
  • TABLE 228. MEXICO RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
  • TABLE 229. MEXICO RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
  • TABLE 230. MEXICO RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
  • TABLE 231. MEXICO RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 232. MEXICO RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 233. MEXICO RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 234. MEXICO RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 235. MEXICO RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 236. MEXICO RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 237. MEXICO RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 238. MEXICO RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 239. MEXICO RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 240. MEXICO RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 241. MEXICO RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 242. MEXICO RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 243. MEXICO RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. MEXICO RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. MEXICO RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. MEXICO RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. UNITED STATES RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. UNITED STATES RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
  • TABLE 252. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
  • TABLE 253. UNITED STATES RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
  • TABLE 254. UNITED STATES RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
  • TABLE 255. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 256. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 257. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 258. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 259. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 260. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 261. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 262. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 263. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 264. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 265. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 266. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 267. UNITED STATES RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. UNITED STATES RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED STATES RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED STATES RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 299. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
  • TABLE 304. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
  • TABLE 305. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
  • TABLE 306. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
  • TABLE 307. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 308. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 309. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 310. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 311. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 312. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 313. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 314. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 315. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 316. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 317. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 318. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 319. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 320. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 321. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. CHINA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. CHINA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 325. CHINA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. CHINA RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. CHINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
  • TABLE 328. CHINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
  • TABLE 329. CHINA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
  • TABLE 330. CHINA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
  • TABLE 331. CHINA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 332. CHINA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 333. CHINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 334. CHINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 335. CHINA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 336. CHINA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 337. CH